Role of MRI of the breast in the evaluation of the symptomatic patient

Current Opinion in Obstetrics and Gynecology

Volumn 21, Issue 1, 2009, Pages 74-79

  Van Goethem, Mireille ^a   Verslegers, Inge ^a   Biltjes, Isabelle ^a   Hufkens, Godelieve ^a   Parizel, Paul M ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Breast; Diagnosis; MRI

Indexed keywords

BREAST CARCINOMA; BREAST DISCHARGE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; COST EFFECTIVENESS ANALYSIS; DIFFERENTIAL DIAGNOSIS; HUMAN; MAMMOGRAPHY; MASTITIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SENSITIVITY AND SPECIFICITY; SILICONE PROSTHESIS;

BIOPSY; BREAST; BREAST IMPLANTS; BREAST NEOPLASMS; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTITIS; NEOPLASM STAGING; NIPPLES; RECURRENCE; SENSITIVITY AND SPECIFICITY;

EID: 59149085996     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e328321e45e     Document Type: Review

References (63)

1. Heywang-Köbrunner S. Diagnosis of breast cancer with MR/overview after 1250 patients. Electromedica 1993; 61:43-52.
2. Hazard HW, Hansen NM. Image-guided procedures for breast masses. Adv Surg 2007; 41:257-272. Image-guided, large-core biopsy systems enable successful and accurate tissue sampling and, ultimately, diagnosis of a suspicious lesion. Care must be taken to ensure correlation between imaging findings and pathologic diagnosis; if the two are discordant, further investigation is mandatory.
3. BlueCross BlueShield Association (BCBSA), Technology Evaluation Center (TEC). Magnetic resonance imaging of the breast: differential diagnosis of a breast lesion to avoid biopsy. TEC Assessment Program. [Accessed 5 March 2004].
4. Hrung JM, Sonnad SS, Schwartz JS, Langlotz CP. Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad Radiol 1999; 6:387-397.
5. Peters NH, Borel Rinkes IH, Zuithoff NP, et al., Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 2008; 246:116-124. A meta-analysis: MRI of the breast has high sensitivity and lower specificity in the evaluation of breast lesions.
6. Vassiou K, Kanavou T, Vlychou M, et al., Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound. Eur J Radiol 2008 [Epub ahead of print].
7. Turnbull LW. Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer. NMR Biomed 2008 [Epub ahead of print]. MRI has a number of limitations including the overlap in enhancement patterns between malignant and benign disease. Research continues, focusing on the use of higher field strengths with improved spatial and temporal resolution data improving understanding of the mechanism of contrast enhancement.
8. Schmitz AC, Peters NH, Veldhuis WB, et al., Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps. Eur Radiol 2008; 18:355-364.
9. Sinha S, Sinha U. Recent advances in breast MRI and MRS. NMR Biomed 2008 [Epub ahead of print].
10. Kuroki Y, Nasu K. Advances in breast MRI: diffusion-weighted imaging of the breast. Breast Cancer 2008; 15:212-217. Diffusion-weighted imaging (DWI) is expected to play an important role in future breast cancer diagnosis. DWI, however, is not a complete method of diagnosis. Limits exist in spatial resolution and problems with apparent diffusion coefficient (ADC).
11. Jansen SA, Fan X, Karczmar GS, et al., Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast-enhanced MRI: a sensitivity and specificity study. Magn Reson Med 2008; 59:747- 754.
12. Schnall M, Orel S. Breast MR imaging in the diagnostic setting. Magn Reson Imaging Clin N Am 2006; 14:329-337.
13. Sharma R, Dietz J, Wright H, et al., Comparative analysis of minimally invasive microductectomy versus major duct excision in patients with pathologic nipple discharge. Surgery 2005; 138:591-596.
14. Markopoulos C, Mantas D, Kouskos E, et al., Surgical management of nipple discharge. Eur J Gynaecol Oncol 2006; 27:275-278.
15. Orel SG, Dougherty CS, Reynolds C, et al., MR imaging in patients with nipple discharge: initial experience. Radiology 2000; 216:248-254.
16. Nakahara H, Namba K, Watanabe R, et al., A comparison of MR imaging, galactography and ultrasonography in patients with nipple discharge. Breast Cancer 2003; 10:320-329.
17. Kramer SC, Rieber A, Gorich J, et al., Diagnosis of papillomas of the breast: value of magnetic resonance mammography in comparison with galactography. Eur Radiol 2000; 10:1733-1736.
18. Ballesio L, Maggi C, Savelli S, et al., Role of breast magnetic resonance imaging (MRI) in patients with unilateral nipple discharge: preliminary study. Radiol Med 2008; 113:249-264. MRI can be considered a valuable examination in the diagnosis of suspected ductal disease and an alternative to galactography when the latter cannot be used.
19. Renz DM, Baltzer PA, Böttcher J, et al., Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study. Eur Radiol 2008; 18:2370-2380.
20. Yang WT, Le-Petross HT, Macapinlac H, et al., Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat 2008; 109:417-426. MR has a role in detecting a primary breast parenchymal lesion in inflammatory carcinoma.
21. Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer 2004; 100:1776-1785.
22. Bleicher RJ, Morrow M. MRI and breast cancer: role in detection, diagnosis, and staging. Oncology 2007; 21:1521 -1528.
23. Henry-Tillman RS, Harms SE, Westbrook KC, et al., Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. Am J Surg 1999; 178:496-500.
24. Sella T, Maly B, Sosna J, et al., Breast magnetic resonance imaging characteristics in women with occult primary breast carcinoma. Isr Med Assoc J 2008; 10:448-452. MRI detects the primary occult tumor in a high percentage of cases.
25. Orel SG, Weinstein SP, Schnall MD, et al., Breast MR imaging in patients with axillary node metastases and primary malignancy. Radiology 1999; 212:543-549.
26. Schorn C, Fischer U, Luftner-Nagel S, et al., MRI of the breast in patients with metastatic disease of unknown primary. Eur Radiol 1999; 9:470-473.
27. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999; 213:881 -888.
28. Van Goethem M, Schelfout K, Dijckmans L, et al., MR mammography in the preoperative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur Radiol 2004; 14:809-816.
29. Schelfout K, Van Goethem M, Kersschot E, et al., Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 2004; 30:501-507.
30. BlueCross BlueShield Association (BCBSA), Technology Evaluation Centre (TEC). Magnetic resonance imaging of the breast for preoperative evaluation in patients with localized breast cancer. TEC Assesment Program 2004; 18.
31. Schnall MD, Blume J, Bluemke DA, et al., MRI detection of distinct incidental cancer in women with primary cancer. J Surg Oncol 2005; 92:32-38.
32. Kerslake RW, Carleton PJ, Fox JN, et al., Dynamic gradient-echo and fat- suppressed spin-echo contrast-enhanced of the breast. Clin Radiol 1995; 50:440-454.
33. Soderstrom CE, Harms SE, Copit DS, et al., Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 1996; 201:427-432.
34. Mumtaz H, Davidson T, Hall-Craggs MA, et al., Comparison of magnetic resonance imaging and conventional triple assessment in locally recurrent breast cancer. Br J Surg 1997; 84:1147-1151.
35. Satake H, Shimamoto K, Sawaki A, et al., Role of ultrasonography in the detection of intraductal spread of cancer: correlation with pathologic findings, mammography and MR. Eur Radiol 2000; 10:1726-1732.
36. Van Goethem M, Schelfout K, Kersschot E, et al., MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. Eur J Radiol 2007; 62:273-282.
37. Kristoffersen Wiberg M, Aspelin P, Sylvan M, Bone B. Comparison of lesion size estimated by dynamic MR imaging, mammography histopathology in breast neoplasms. Eur Radiol 2003; 13:1207-1212.
38. Hata T, Takahashi H, Watanabe K, et al., Magnetic resonance imaging for preoperative evaluation of breast comparative study with mammography and ultrasonography. J Am Coll Surg 2004; 198:190-197.
39. Houssami N, Ciatto S, Macaskill P, et al., Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008; 26:3248-3258.
40. Grobmyer SR, Mortellaro VE, Marshall J, et al., Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy? J Am Coll Surg 2008; 206:1045-1050.
41. Lehman CD, Gatsonis C, Kuhl CK, et al., MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007; 356:1295-1303.
42. Liberman L. Breast MR imaging in assessing extent of disease. Magn Reson Imaging Clin N Am 2006; 14:339-349.
43. Weinstein SP, Orel SG, Heller R, et al., MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol 2001; 176:399-406.
44. Bedrosian I, Mick R, Orel SG, et al., Changes in the surgical management of patients with breast carcinoma on preoperative magnetic resonance imaging. Cancer 2003; 98:468-473.
45. Rodenko GN, Harms SE, Pruneda JM, et al., MR imaging in the management before surgery of lobular carcinoma of breast: correlation with pathology. AJR Am J Roentgenol 1996; 167:1415-1419.
46. Kneeshaw PJ, Turnbull LW, Smith A, Drew PJ. Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. Eur J Surg Oncol 2003; 29:32-37.
47. Diekmann F, Diekmann S, Beljavskaja M, et al., Preoperative MRT of the breast in invasive lobular carcinoma in comparison with invasive ductal carcinoma. Rofo 2004; 176:544-549.
48. Schelfout K, Van Goethem M, Kersschot E, et al., Preoperative breast MRI in patients with invasive lobular breast. Eur Radiol 2004; 14:1209-1216.
49. Kepple J, Layeeque R, Klimberg VS, et al., Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am J Surg 2005; 190:623-627.
50. Mann RM, Hoogeveen YL, Blickman JG, Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat 2008; 107:1-14. A review of the currently published literature. This analysis indicates MRI to be valuable in the work-up of ILC. It provides additional knowledge that cannot be obtained by conventional imaging modalities, which can be helpful in patient treatment.
51. Echevarria JJ, Lopez-Ruiz JA, Martin D, et al., Usefulness of MRI in detecting occult breast cancer associated with Paget's disease of the nipple-areolar complex. Br J Radiol 2004; 77:1036-1039.
52. Frei KA, Bonel HM, Pelte MF, et al., Paget disease of the breast: findings at magnetic resonance imaging histopathologic correlation. Invest Radiol 2005; 40:363-367.
53. Fischer U, Zachariae O, Baum F, et al., The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004; 14:1725-1731.
54. Solin LJ, Orel SG, Hwang WT, et al., Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008; 26:352-353.
55. Rieber A, Merkle E, Zeitler H, et al., Value of MR mammography in the detection and exclusion of recurrent carcinoma. J Comput Assist Tomogr 1997; 21:780-784.
56. Drew PJ, Kerin MJ, Turnbull LW, et al., Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast. Ann Surg Oncol 1998; 5:265-270.
57. BlueCross BlueShield Association (BCBSA), Technology Evaluation Center (TEC). Breast MRI for detection or diagnosis of primary or recurrent breast cancer. TEC Assessment Program. 15 February 2006.
58. Davis PL, McCarty KS Jr. Sensitivity of enhanced MRI for the detection of breast cancer: new, multicentric, residual, and recurrent. Eur Radiol 1997; 7 (Suppl 5):289-298.
59. Samuels JB, Rohrich RJ, Weatherall PT, et al., Radiographic diagnosis of breast implant rupture: current status and comparison of techniques. Plast Reconstr Surg 1995; 96:865-877.
60. Pfleiderer B, Heindel W. MRI and MR spectroscopy after silicone breast implants in the female breast. Rofo 2001; 173:571 -579.
61. Middleton MS. Magnetic resonance evaluation of breast implants and soft- tissue. Top Magn Reson Imaging 1998; 9:92-137.
62. Cher DJ, Conwell JA, Mandel JS. MRI for detecting silicone breast implant rupture: metaanalysis and implications. Ann Hast Surg 2001; 47:367-380.
63. Handel N. The effect of silicone implants on the diagnosis, prognosis, and treatment of breast cancer. Plast Reconstr Surg 2007; 120:81 S-93S. Mammography remains the most reliable tool for diagnosing early breast cancer in augmented patients.